id	sid	tid	token	lemma	pos
ct-9952	1	1	validation	validation	NOUN
ct-9952	1	2	of	of	ADP
ct-9952	1	3	an	an	DET
ct-9952	1	4	in	in	ADP
ct-9952	1	5	-	-	PUNCT
ct-9952	1	6	clinic	clinic	NOUN
ct-9952	1	7	immunoassay	immunoassay	NOUN
ct-9952	1	8	for	for	ADP
ct-9952	1	9	measurement	measurement	NOUN
ct-9952	1	10	of	of	ADP
ct-9952	1	11	canine	canine	PROPN
ct-9952	1	12	progesterone	progesterone	NOUN
ct-9952	1	13	validation	validation	NOUN
ct-9952	1	14	of	of	ADP
ct-9952	1	15	an	an	DET
ct-9952	1	16	in	in	ADP
ct-9952	1	17	-	-	PUNCT
ct-9952	1	18	clinic	clinic	NOUN
ct-9952	1	19	immunoassay	immunoassay	NOUN
ct-9952	1	20	for	for	ADP
ct-9952	1	21	measurement	measurement	NOUN
ct-9952	1	22	of	of	ADP
ct-9952	1	23	canine	canine	PROPN
ct-9952	1	24	progesterone	progesterone	PROPN
ct-9952	1	25	elizabeth	elizabeth	PROPN
ct-9952	1	26	schooley	schooley	PROPN
ct-9952	1	27	,	,	PUNCT
ct-9952	1	28	edward	edward	PROPN
ct-9952	1	29	obare	obare	PROPN
ct-9952	1	30	,	,	PUNCT
ct-9952	1	31	maha	maha	PROPN
ct-9952	1	32	yerramilli	yerramilli	PROPN
ct-9952	1	33	,	,	PUNCT
ct-9952	1	34	jun	jun	PROPN
ct-9952	1	35	li	li	PROPN
ct-9952	1	36	,	,	PUNCT
ct-9952	1	37	tiffany	tiffany	PROPN
ct-9952	1	38	glavan	glavan	PROPN
ct-9952	1	39	idexx	idexx	PROPN
ct-9952	1	40	laboratories	laboratory	NOUN
ct-9952	1	41	,	,	PUNCT
ct-9952	1	42	inc	inc	PROPN
ct-9952	1	43	.	.	PROPN
ct-9952	1	44	,	,	PUNCT
ct-9952	1	45	westbrook	westbrook	PROPN
ct-9952	1	46	,	,	PUNCT
ct-9952	1	47	me	i	PRON
ct-9952	1	48	idexx	idexx	PROPN
ct-9952	1	49	recently	recently	ADV
ct-9952	1	50	introduced	introduce	VERB
ct-9952	1	51	an	an	DET
ct-9952	1	52	immunoassay	immunoassay	NOUN
ct-9952	1	53	to	to	PART
ct-9952	1	54	measure	measure	VERB
ct-9952	1	55	canine	canine	VERB
ct-9952	1	56	progesterone	progesterone	NOUN
ct-9952	1	57	on	on	ADP
ct-9952	1	58	the	the	DET
ct-9952	1	59	catalyst	catalyst	NOUN
ct-9952	1	60	®	®	NOUN
ct-9952	1	61	suite	suite	NOUN
ct-9952	1	62	of	of	ADP
ct-9952	1	63	chemistry	chemistry	NOUN
ct-9952	1	64	analyzers	analyzer	NOUN
ct-9952	1	65	.	.	PUNCT
ct-9952	2	1	objectives	objective	NOUN
ct-9952	2	2	were	be	AUX
ct-9952	2	3	to	to	PART
ct-9952	2	4	:	:	PUNCT
ct-9952	2	5	(	(	PUNCT
ct-9952	2	6	1	1	X
ct-9952	2	7	)	)	PUNCT
ct-9952	2	8	validate	validate	NOUN
ct-9952	2	9	lc	lc	ADP
ct-9952	3	1	ms	ms	PROPN
ct-9952	3	2	for	for	ADP
ct-9952	3	3	measurement	measurement	NOUN
ct-9952	3	4	of	of	ADP
ct-9952	3	5	canine	canine	NOUN
ct-9952	3	6	plasma	plasma	NOUN
ct-9952	3	7	progesterone	progesterone	NOUN
ct-9952	3	8	concentrations	concentration	NOUN
ct-9952	3	9	;	;	PUNCT
ct-9952	3	10	(	(	PUNCT
ct-9952	3	11	2	2	X
ct-9952	3	12	)	)	PUNCT
ct-9952	3	13	evaluate	evaluate	VERB
ct-9952	3	14	accuracy	accuracy	NOUN
ct-9952	3	15	of	of	ADP
ct-9952	3	16	the	the	DET
ct-9952	3	17	in	in	ADP
ct-9952	3	18	-	-	PUNCT
ct-9952	3	19	clinic	clinic	NOUN
ct-9952	3	20	catalyst	catalyst	NOUN
ct-9952	3	21	®	®	NOUN
ct-9952	3	22	progesterone	progesterone	NOUN
ct-9952	3	23	test	test	NOUN
ct-9952	3	24	compared	compare	VERB
ct-9952	3	25	to	to	ADP
ct-9952	3	26	results	result	NOUN
ct-9952	3	27	obtained	obtain	VERB
ct-9952	3	28	by	by	ADP
ct-9952	3	29	lc	lc	PROPN
ct-9952	3	30	ms	ms	PROPN
ct-9952	3	31	;	;	PUNCT
ct-9952	3	32	and	and	CCONJ
ct-9952	3	33	(	(	PUNCT
ct-9952	3	34	3	3	X
ct-9952	3	35	)	)	PUNCT
ct-9952	3	36	evaluate	evaluate	VERB
ct-9952	3	37	repeatability	repeatability	NOUN
ct-9952	3	38	of	of	ADP
ct-9952	3	39	the	the	DET
ct-9952	3	40	catalyst	catalyst	NOUN
ct-9952	3	41	®	®	NOUN
ct-9952	3	42	progesterone	progesterone	NOUN
ct-9952	3	43	test	test	NOUN
ct-9952	3	44	across	across	ADP
ct-9952	3	45	multiple	multiple	ADJ
ct-9952	3	46	analyzers	analyzer	NOUN
ct-9952	3	47	.	.	PUNCT
ct-9952	4	1	the	the	DET
ct-9952	4	2	lc	lc	PROPN
ct-9952	4	3	ms	ms	PROPN
ct-9952	4	4	progesterone	progesterone	PROPN
ct-9952	4	5	assay	assay	NOUN
ct-9952	4	6	was	be	AUX
ct-9952	4	7	validated	validate	VERB
ct-9952	4	8	in	in	ADP
ct-9952	4	9	accordance	accordance	NOUN
ct-9952	4	10	with	with	ADP
ct-9952	4	11	fda	fda	PROPN
ct-9952	4	12	guidelines	guideline	NOUN
ct-9952	4	13	for	for	ADP
ct-9952	4	14	linearity	linearity	NOUN
ct-9952	4	15	,	,	PUNCT
ct-9952	4	16	carryover	carryover	NOUN
ct-9952	4	17	,	,	PUNCT
ct-9952	4	18	sensitivity	sensitivity	NOUN
ct-9952	4	19	,	,	PUNCT
ct-9952	4	20	selectivity	selectivity	NOUN
ct-9952	4	21	,	,	PUNCT
ct-9952	4	22	accuracy	accuracy	NOUN
ct-9952	4	23	,	,	PUNCT
ct-9952	4	24	and	and	CCONJ
ct-9952	4	25	precision	precision	NOUN
ct-9952	4	26	.	.	PUNCT
ct-9952	5	1	chromatographic	chromatographic	ADJ
ct-9952	5	2	separation	separation	NOUN
ct-9952	5	3	was	be	AUX
ct-9952	5	4	performed	perform	VERB
ct-9952	5	5	on	on	ADP
ct-9952	5	6	a	a	DET
ct-9952	5	7	shimadzu	shimadzu	ADJ
ct-9952	5	8	nexera	nexera	NOUN
ct-9952	5	9	ultra	ultra	ADJ
ct-9952	5	10	high	high	ADJ
ct-9952	5	11	-	-	PUNCT
ct-9952	5	12	performance	performance	NOUN
ct-9952	5	13	liquid	liquid	ADJ
ct-9952	5	14	chromatograph	chromatograph	NOUN
ct-9952	5	15	using	use	VERB
ct-9952	5	16	acquity	acquity	NOUN
ct-9952	5	17	beh	beh	NOUN
ct-9952	5	18	300	300	NUM
ct-9952	5	19	c4	c4	NOUN
ct-9952	5	20	1.7	1.7	NUM
ct-9952	5	21	µm	µm	NOUN
ct-9952	5	22	,	,	PUNCT
ct-9952	5	23	2.1	2.1	NUM
ct-9952	5	24	x	x	SYM
ct-9952	5	25	100	100	NUM
ct-9952	5	26	mm	mm	PROPN
ct-9952	5	27	analytical	analytical	ADJ
ct-9952	5	28	column	column	NOUN
ct-9952	5	29	with	with	ADP
ct-9952	5	30	analyte	analyte	NOUN
ct-9952	5	31	detection	detection	NOUN
ct-9952	5	32	by	by	ADP
ct-9952	5	33	a	a	DET
ct-9952	5	34	sciex	sciex	NOUN
ct-9952	5	35	api	api	NOUN
ct-9952	5	36	4000	4000	NUM
ct-9952	5	37	mass	mass	NOUN
ct-9952	5	38	spectrometer	spectrometer	NOUN
ct-9952	5	39	with	with	ADP
ct-9952	5	40	multiple	multiple	ADJ
ct-9952	5	41	reaction	reaction	NOUN
ct-9952	5	42	monitoring	monitoring	NOUN
ct-9952	5	43	with	with	ADP
ct-9952	5	44	progesterone-[13c3	progesterone-[13c3	NOUN
ct-9952	5	45	]	]	PUNCT
ct-9952	5	46	as	as	ADP
ct-9952	5	47	an	an	DET
ct-9952	5	48	internal	internal	ADJ
ct-9952	5	49	standard	standard	NOUN
ct-9952	5	50	.	.	PUNCT
ct-9952	6	1	the	the	DET
ct-9952	6	2	dynamic	dynamic	ADJ
ct-9952	6	3	range	range	NOUN
ct-9952	6	4	of	of	ADP
ct-9952	6	5	the	the	DET
ct-9952	6	6	lc	lc	PROPN
ct-9952	6	7	-	-	PUNCT
ct-9952	6	8	ms	ms	PROPN
ct-9952	6	9	assay	assay	PROPN
ct-9952	6	10	is	be	AUX
ct-9952	6	11	0.2	0.2	NUM
ct-9952	6	12	40	40	NUM
ct-9952	6	13	ng	ng	PROPN
ct-9952	6	14	/	/	SYM
ct-9952	6	15	ml	ml	NOUN
ct-9952	6	16	and	and	CCONJ
ct-9952	6	17	accuracy	accuracy	NOUN
ct-9952	6	18	is	be	AUX
ct-9952	6	19	traceable	traceable	ADJ
ct-9952	6	20	to	to	ADP
ct-9952	6	21	the	the	DET
ct-9952	6	22	nist	nist	NOUN
ct-9952	6	23	standard	standard	NOUN
ct-9952	6	24	(	(	PUNCT
ct-9952	6	25	standard	standard	ADJ
ct-9952	6	26	reference	reference	NOUN
ct-9952	6	27	material	material	NOUN
ct-9952	6	28	971	971	NUM
ct-9952	6	29	)	)	PUNCT
ct-9952	6	30	.	.	PUNCT
ct-9952	7	1	the	the	DET
ct-9952	7	2	assay	assay	NOUN
ct-9952	7	3	exceeded	exceed	VERB
ct-9952	7	4	fda	fda	PROPN
ct-9952	7	5	criteria	criterion	NOUN
ct-9952	7	6	of	of	ADP
ct-9952	7	7	intra	intra	ADJ
ct-9952	7	8	/	/	SYM
ct-9952	7	9	inter	inter	ADJ
ct-9952	7	10	day	day	NOUN
ct-9952	7	11	accuracy	accuracy	NOUN
ct-9952	7	12	/	/	SYM
ct-9952	7	13	precision	precision	NOUN
ct-9952	7	14	,	,	PUNCT
ct-9952	7	15	demonstrating	demonstrate	VERB
ct-9952	7	16	imprecision	imprecision	NOUN
ct-9952	7	17	of	of	ADP
ct-9952	7	18	less	less	ADJ
ct-9952	7	19	than	than	ADP
ct-9952	7	20	7	7	NUM
ct-9952	7	21	%	%	NOUN
ct-9952	7	22	cv	cv	NOUN
ct-9952	7	23	and	and	CCONJ
ct-9952	7	24	accuracy	accuracy	NOUN
ct-9952	7	25	within	within	ADP
ct-9952	7	26	95	95	NUM
ct-9952	7	27	108	108	NUM
ct-9952	7	28	%	%	NOUN
ct-9952	7	29	of	of	ADP
ct-9952	7	30	the	the	DET
ct-9952	7	31	expected	expect	VERB
ct-9952	7	32	value	value	NOUN
ct-9952	7	33	over	over	ADP
ct-9952	7	34	the	the	DET
ct-9952	7	35	analyte	analyte	NOUN
ct-9952	7	36	range	range	NOUN
ct-9952	7	37	.	.	PUNCT
ct-9952	8	1	lower	low	ADJ
ct-9952	8	2	limit	limit	NOUN
ct-9952	8	3	of	of	ADP
ct-9952	8	4	quantification	quantification	NOUN
ct-9952	8	5	and	and	CCONJ
ct-9952	8	6	linearity	linearity	NOUN
ct-9952	8	7	studies	study	NOUN
ct-9952	8	8	support	support	VERB
ct-9952	8	9	a	a	DET
ct-9952	8	10	dynamic	dynamic	ADJ
ct-9952	8	11	range	range	NOUN
ct-9952	8	12	of	of	ADP
ct-9952	8	13	0.2	0.2	NUM
ct-9952	8	14	40	40	NUM
ct-9952	8	15	ng	ng	PROPN
ct-9952	8	16	/	/	SYM
ct-9952	8	17	ml	ml	PROPN
ct-9952	8	18	(	(	PUNCT
ct-9952	8	19	s	s	NOUN
ct-9952	8	20	/	/	SYM
ct-9952	8	21	n	n	NOUN
ct-9952	8	22	e	e	NOUN
ct-9952	8	23	10	10	NUM
ct-9952	8	24	;	;	PUNCT
ct-9952	8	25	r2	r2	NOUN
ct-9952	8	26	=	=	NOUN
ct-9952	8	27	0.99	0.99	NUM
ct-9952	8	28	)	)	PUNCT
ct-9952	8	29	.	.	PUNCT
ct-9952	9	1	the	the	DET
ct-9952	9	2	lower	low	ADJ
ct-9952	9	3	limit	limit	NOUN
ct-9952	9	4	of	of	ADP
ct-9952	9	5	quantitation	quantitation	NOUN
ct-9952	9	6	was	be	AUX
ct-9952	9	7	0.2	0.2	NUM
ct-9952	9	8	ng	ng	NOUN
ct-9952	9	9	/	/	SYM
ct-9952	9	10	ml	ml	PROPN
ct-9952	9	11	and	and	CCONJ
ct-9952	9	12	had	have	VERB
ct-9952	9	13	a	a	DET
ct-9952	9	14	linearity	linearity	NOUN
ct-9952	9	15	with	with	ADP
ct-9952	9	16	an	an	DET
ct-9952	9	17	r2	r2	NOUN
ct-9952	9	18	value	value	NOUN
ct-9952	9	19	of	of	ADP
ct-9952	9	20	0.99	0.99	NUM
ct-9952	9	21	or	or	CCONJ
ct-9952	9	22	better	well	ADJ
ct-9952	9	23	.	.	PUNCT
ct-9952	10	1	there	there	PRON
ct-9952	10	2	was	be	VERB
ct-9952	10	3	no	no	DET
ct-9952	10	4	evidence	evidence	NOUN
ct-9952	10	5	of	of	ADP
ct-9952	10	6	carryover	carryover	NOUN
ct-9952	10	7	or	or	CCONJ
ct-9952	10	8	interferences	interference	NOUN
ct-9952	10	9	of	of	ADP
ct-9952	10	10	progesterone	progesterone	NOUN
ct-9952	10	11	/	/	SYM
ct-9952	10	12	progesterone[2,3,4	progesterone[2,3,4	NOUN
ct-9952	10	13	-	-	PUNCT
ct-9952	10	14	13c3	13c3	NUM
ct-9952	10	15	]	]	PUNCT
ct-9952	10	16	is	be	AUX
ct-9952	10	17	m	m	PROPN
ct-9952	10	18	/	/	SYM
ct-9952	10	19	z	z	NOUN
ct-9952	10	20	transitions	transition	NOUN
ct-9952	10	21	observed	observe	VERB
ct-9952	10	22	.	.	PUNCT
ct-9952	11	1	to	to	PART
ct-9952	11	2	evaluate	evaluate	VERB
ct-9952	11	3	the	the	DET
ct-9952	11	4	catalyst	catalyst	NOUN
ct-9952	11	5	®	®	NOUN
ct-9952	11	6	progesterone	progesterone	NOUN
ct-9952	11	7	test	test	NOUN
ct-9952	11	8	compared	compare	VERB
ct-9952	11	9	to	to	ADP
ct-9952	11	10	lc	lc	PROPN
ct-9952	11	11	ms	ms	PROPN
ct-9952	11	12	,	,	PUNCT
ct-9952	11	13	107	107	NUM
ct-9952	11	14	blood	blood	NOUN
ct-9952	11	15	samples	sample	NOUN
ct-9952	11	16	were	be	AUX
ct-9952	11	17	collected	collect	VERB
ct-9952	11	18	from	from	ADP
ct-9952	11	19	peri	peri	ADJ
ct-9952	11	20	ovulatory	ovulatory	ADJ
ct-9952	11	21	bitches	bitch	NOUN
ct-9952	11	22	presented	present	VERB
ct-9952	11	23	to	to	ADP
ct-9952	11	24	3	3	NUM
ct-9952	11	25	veterinary	veterinary	ADJ
ct-9952	11	26	hospitals	hospital	NOUN
ct-9952	11	27	for	for	ADP
ct-9952	11	28	breeding	breeding	NOUN
ct-9952	11	29	management	management	NOUN
ct-9952	11	30	.	.	PUNCT
ct-9952	12	1	within	within	ADP
ct-9952	12	2	30	30	NUM
ct-9952	12	3	minutes	minute	NOUN
ct-9952	12	4	after	after	ADP
ct-9952	12	5	collection	collection	NOUN
ct-9952	12	6	,	,	PUNCT
ct-9952	12	7	lithium	lithium	NOUN
ct-9952	12	8	heparin	heparin	ADJ
ct-9952	12	9	plasma	plasma	NOUN
ct-9952	12	10	was	be	AUX
ct-9952	12	11	separated	separate	VERB
ct-9952	12	12	from	from	ADP
ct-9952	12	13	erythrocytes	erythrocyte	NOUN
ct-9952	12	14	.	.	PUNCT
ct-9952	13	1	plasma	plasma	NOUN
ct-9952	13	2	samples	sample	NOUN
ct-9952	13	3	were	be	AUX
ct-9952	13	4	analyzed	analyze	VERB
ct-9952	13	5	both	both	CCONJ
ct-9952	13	6	on	on	ADP
ct-9952	13	7	the	the	DET
ct-9952	13	8	catalyst	catalyst	NOUN
ct-9952	13	9	®	®	NOUN
ct-9952	13	10	progesterone	progesterone	NOUN
ct-9952	13	11	assay	assay	NOUN
ct-9952	13	12	(	(	PUNCT
ct-9952	13	13	within	within	ADP
ct-9952	13	14	48	48	NUM
ct-9952	13	15	hours	hour	NOUN
ct-9952	13	16	after	after	ADP
ct-9952	13	17	collection	collection	NOUN
ct-9952	13	18	)	)	PUNCT
ct-9952	13	19	and	and	CCONJ
ct-9952	13	20	lc	lc	NOUN
ct-9952	13	21	ms	ms	PROPN
ct-9952	13	22	at	at	ADP
ct-9952	13	23	idexx	idexx	PROPN
ct-9952	13	24	r&d	r&d	PROPN
ct-9952	13	25	(	(	PUNCT
ct-9952	13	26	within	within	ADP
ct-9952	13	27	1	1	NUM
ct-9952	13	28	week	week	NOUN
ct-9952	13	29	after	after	ADP
ct-9952	13	30	collection	collection	NOUN
ct-9952	13	31	)	)	PUNCT
ct-9952	13	32	.	.	PUNCT
ct-9952	14	1	precision	precision	NOUN
ct-9952	14	2	was	be	AUX
ct-9952	14	3	assessed	assess	VERB
ct-9952	14	4	by	by	ADP
ct-9952	14	5	repeated	repeat	VERB
ct-9952	14	6	analysis	analysis	NOUN
ct-9952	14	7	(	(	PUNCT
ct-9952	14	8	80	80	NUM
ct-9952	14	9	total	total	ADJ
ct-9952	14	10	replicates	replicate	NOUN
ct-9952	14	11	each	each	PRON
ct-9952	14	12	)	)	PUNCT
ct-9952	14	13	of	of	ADP
ct-9952	14	14	3	3	NUM
ct-9952	14	15	control	control	NOUN
ct-9952	14	16	fluids	fluid	NOUN
ct-9952	14	17	in	in	ADP
ct-9952	14	18	the	the	DET
ct-9952	14	19	range	range	NOUN
ct-9952	14	20	of	of	ADP
ct-9952	14	21	clinical	clinical	ADJ
ct-9952	14	22	interest	interest	NOUN
ct-9952	14	23	.	.	PUNCT
ct-9952	15	1	statistical	statistical	ADJ
ct-9952	15	2	analyses	analysis	NOUN
ct-9952	15	3	were	be	AUX
ct-9952	15	4	performed	perform	VERB
ct-9952	15	5	using	use	VERB
ct-9952	15	6	jmp	jmp	PROPN
ct-9952	15	7	®	®	PROPN
ct-9952	15	8	14.0.0	14.0.0	NUM
ct-9952	15	9	.	.	PUNCT
ct-9952	16	1	results	result	NOUN
ct-9952	16	2	are	be	AUX
ct-9952	16	3	reported	report	VERB
ct-9952	16	4	with	with	ADP
ct-9952	16	5	95	95	NUM
ct-9952	16	6	%	%	NOUN
ct-9952	16	7	confidence	confidence	NOUN
ct-9952	16	8	limits	limit	NOUN
ct-9952	16	9	in	in	ADP
ct-9952	16	10	parentheses	parenthesis	NOUN
ct-9952	16	11	.	.	PUNCT
ct-9952	17	1	mean	mean	VERB
ct-9952	17	2	progesterone	progesterone	NOUN
ct-9952	17	3	obtained	obtain	VERB
ct-9952	17	4	by	by	ADP
ct-9952	17	5	lc	lc	PROPN
ct-9952	17	6	ms	ms	PROPN
ct-9952	17	7	was	be	AUX
ct-9952	17	8	5.6	5.6	NUM
ct-9952	17	9	ng	ng	NOUN
ct-9952	17	10	/	/	SYM
ct-9952	17	11	ml	ml	PROPN
ct-9952	17	12	(	(	PUNCT
ct-9952	17	13	range	range	NOUN
ct-9952	17	14	:	:	PUNCT
ct-9952	17	15	0.2	0.2	NUM
ct-9952	17	16	to	to	PART
ct-9952	17	17	19.4	19.4	NUM
ct-9952	17	18	ng	ng	NOUN
ct-9952	17	19	/	/	SYM
ct-9952	17	20	ml	ml	NOUN
ct-9952	17	21	)	)	PUNCT
ct-9952	17	22	.	.	PUNCT
ct-9952	18	1	catalyst	catalyst	NOUN
ct-9952	18	2	®	®	NOUN
ct-9952	18	3	progesterone	progesterone	NOUN
ct-9952	18	4	assay	assay	NOUN
ct-9952	18	5	mean	mean	PROPN
ct-9952	18	6	progesterone	progesterone	NOUN
ct-9952	18	7	was	be	AUX
ct-9952	18	8	5.9	5.9	NUM
ct-9952	18	9	ng	ng	NOUN
ct-9952	18	10	/	/	SYM
ct-9952	18	11	ml	ml	PROPN
ct-9952	18	12	(	(	PUNCT
ct-9952	18	13	range	range	NOUN
ct-9952	18	14	:	:	PUNCT
ct-9952	18	15	0.2	0.2	NUM
ct-9952	18	16	to	to	PART
ct-9952	18	17	19.3	19.3	NUM
ct-9952	18	18	ng	ng	NOUN
ct-9952	18	19	/	/	SYM
ct-9952	18	20	ml	ml	PROPN
ct-9952	18	21	)	)	PUNCT
ct-9952	18	22	.	.	PUNCT
ct-9952	19	1	passing	pass	VERB
ct-9952	19	2	bablok	bablok	PROPN
ct-9952	19	3	regression	regression	NOUN
ct-9952	19	4	analysis	analysis	NOUN
ct-9952	19	5	had	have	VERB
ct-9952	19	6	an	an	DET
ct-9952	19	7	intercept	intercept	NOUN
ct-9952	19	8	-0.07	-0.07	INTJ
ct-9952	19	9	ng	ng	NOUN
ct-9952	19	10	/	/	SYM
ct-9952	19	11	ml	ml	PROPN
ct-9952	19	12	(	(	PUNCT
ct-9952	19	13	-0.2	-0.2	NOUN
ct-9952	19	14	0.02	0.02	NUM
ct-9952	19	15	)	)	PUNCT
ct-9952	19	16	,	,	PUNCT
ct-9952	19	17	slope	slope	NOUN
ct-9952	19	18	1.07	1.07	NUM
ct-9952	19	19	(	(	PUNCT
ct-9952	19	20	1.02	1.02	NUM
ct-9952	19	21	1.12	1.12	NUM
ct-9952	19	22	)	)	PUNCT
ct-9952	19	23	,	,	PUNCT
ct-9952	19	24	and	and	CCONJ
ct-9952	19	25	tau	tau	PROPN
ct-9952	19	26	0.89	0.89	NUM
ct-9952	19	27	.	.	PUNCT
ct-9952	20	1	pearson	pearson	PROPN
ct-9952	20	2	’s	’s	PART
ct-9952	20	3	correlation	correlation	NOUN
ct-9952	20	4	coefficient	coefficient	NOUN
ct-9952	20	5	was	be	AUX
ct-9952	20	6	0.98	0.98	NUM
ct-9952	20	7	.	.	PUNCT
ct-9952	21	1	the	the	DET
ct-9952	21	2	mean	mean	ADJ
ct-9952	21	3	difference	difference	NOUN
ct-9952	21	4	(	(	PUNCT
ct-9952	21	5	bland	bland	ADJ
ct-9952	21	6	altman	altman	PROPN
ct-9952	21	7	plot	plot	NOUN
ct-9952	21	8	)	)	PUNCT
ct-9952	21	9	was	be	AUX
ct-9952	21	10	0.27	0.27	NUM
ct-9952	21	11	ng	ng	PROPN
ct-9952	21	12	/	/	SYM
ct-9952	21	13	ml	ml	PROPN
ct-9952	21	14	(	(	PUNCT
ct-9952	21	15	0.06	0.06	NUM
ct-9952	21	16	0.47	0.47	NUM
ct-9952	21	17	;	;	PUNCT
ct-9952	21	18	sem	sem	PROPN
ct-9952	21	19	0.1	0.1	NUM
ct-9952	21	20	ng	ng	PROPN
ct-9952	21	21	/	/	SYM
ct-9952	21	22	ml	ml	NOUN
ct-9952	21	23	)	)	PUNCT
ct-9952	21	24	.	.	PUNCT
ct-9952	22	1	increased	increase	VERB
ct-9952	22	2	variation	variation	NOUN
ct-9952	22	3	at	at	ADP
ct-9952	22	4	the	the	DET
ct-9952	22	5	higher	high	ADJ
ct-9952	22	6	end	end	NOUN
ct-9952	22	7	of	of	ADP
ct-9952	22	8	the	the	DET
ct-9952	22	9	dynamic	dynamic	ADJ
ct-9952	22	10	range	range	NOUN
ct-9952	22	11	(	(	PUNCT
ct-9952	22	12	>	>	X
ct-9952	22	13	16	16	NUM
ct-9952	22	14	ng	ng	PROPN
ct-9952	22	15	/	/	SYM
ct-9952	22	16	ml	ml	PROPN
ct-9952	22	17	)	)	PUNCT
ct-9952	22	18	,	,	PUNCT
ct-9952	22	19	where	where	SCONJ
ct-9952	22	20	unlikely	unlikely	ADJ
ct-9952	22	21	to	to	PART
ct-9952	22	22	impact	impact	VERB
ct-9952	22	23	clinical	clinical	ADJ
ct-9952	22	24	decisions	decision	NOUN
ct-9952	22	25	.	.	PUNCT
ct-9952	23	1	in	in	ADP
ct-9952	23	2	the	the	DET
ct-9952	23	3	precision	precision	NOUN
ct-9952	23	4	study	study	NOUN
ct-9952	23	5	,	,	PUNCT
ct-9952	23	6	mean	mean	VERB
ct-9952	23	7	concentrations	concentration	NOUN
ct-9952	23	8	of	of	ADP
ct-9952	23	9	0.43	0.43	NUM
ct-9952	23	10	ng	ng	NOUN
ct-9952	23	11	/	/	SYM
ct-9952	23	12	ml	ml	PROPN
ct-9952	23	13	(	(	PUNCT
ct-9952	23	14	±	±	X
ct-9952	23	15	sd	sd	ADP
ct-9952	23	16	0.07	0.07	NUM
ct-9952	23	17	)	)	PUNCT
ct-9952	23	18	,	,	PUNCT
ct-9952	23	19	3.5	3.5	NUM
ct-9952	23	20	ng	ng	NOUN
ct-9952	23	21	/	/	SYM
ct-9952	23	22	ml	ml	PROPN
ct-9952	23	23	(	(	PUNCT
ct-9952	23	24	±	±	NOUN
ct-9952	23	25	sd	sd	ADP
ct-9952	23	26	0.28	0.28	NUM
ct-9952	23	27	)	)	PUNCT
ct-9952	23	28	and	and	CCONJ
ct-9952	23	29	16.0	16.0	NUM
ct-9952	23	30	ng	ng	NOUN
ct-9952	23	31	/	/	SYM
ct-9952	23	32	ml	ml	PROPN
ct-9952	23	33	(	(	PUNCT
ct-9952	23	34	±	±	NUM
ct-9952	23	35	sd	sd	ADP
ct-9952	23	36	1.35	1.35	NUM
ct-9952	23	37	)	)	PUNCT
ct-9952	23	38	.	.	PUNCT
ct-9952	24	1	catalyst	catalyst	NOUN
ct-9952	24	2	®	®	NOUN
ct-9952	24	3	progesterone	progesterone	NOUN
ct-9952	24	4	test	test	NOUN
ct-9952	24	5	can	can	AUX
ct-9952	24	6	be	be	AUX
ct-9952	24	7	used	use	VERB
ct-9952	24	8	for	for	ADP
ct-9952	24	9	in	in	ADP
ct-9952	24	10	clinic	clinic	NOUN
ct-9952	24	11	measurement	measurement	NOUN
ct-9952	24	12	of	of	ADP
ct-9952	24	13	canine	canine	NOUN
ct-9952	24	14	plasma	plasma	NOUN
ct-9952	24	15	progesterone	progesterone	NOUN
ct-9952	24	16	concentrations	concentration	NOUN
ct-9952	24	17	,	,	PUNCT
ct-9952	24	18	due	due	ADP
ct-9952	24	19	to	to	ADP
ct-9952	24	20	its	its	PRON
ct-9952	24	21	good	good	ADJ
ct-9952	24	22	correlation	correlation	NOUN
ct-9952	24	23	to	to	ADP
ct-9952	24	24	the	the	DET
ct-9952	24	25	reference	reference	NOUN
ct-9952	24	26	method	method	NOUN
ct-9952	24	27	,	,	PUNCT
ct-9952	24	28	lc	lc	PROPN
ct-9952	24	29	ms	ms	PROPN
ct-9952	24	30	,	,	PUNCT
ct-9952	24	31	and	and	CCONJ
ct-9952	24	32	good	good	ADJ
ct-9952	24	33	precision	precision	NOUN
ct-9952	24	34	in	in	ADP
ct-9952	24	35	the	the	DET
ct-9952	24	36	range	range	NOUN
ct-9952	24	37	of	of	ADP
ct-9952	24	38	clinical	clinical	ADJ
ct-9952	24	39	interest	interest	NOUN
ct-9952	24	40	.	.	PUNCT
ct-9952	25	1	keywords	keyword	NOUN
ct-9952	25	2	:	:	PUNCT
ct-9952	25	3	progesterone	progesterone	NOUN
ct-9952	25	4	,	,	PUNCT
ct-9952	25	5	canine	canine	NOUN
ct-9952	25	6	,	,	PUNCT
ct-9952	25	7	lc	lc	PROPN
ct-9952	25	8	ms	ms	PROPN
ct-9952	25	9	,	,	PUNCT
ct-9952	25	10	immunoassay	immunoassay	VERB
ct-9952	25	11	413	413	NUM
ct-9952	25	12	clinical	clinical	ADJ
ct-9952	25	13	theriogenology	theriogenology	NOUN
ct-9952	25	14	•	•	NOUN
ct-9952	25	15	volume	volume	NOUN
ct-9952	25	16	11	11	NUM
ct-9952	25	17	,	,	PUNCT
ct-9952	25	18	number	number	NOUN
ct-9952	25	19	3	3	NUM
ct-9952	25	20	•	•	NUM
ct-9952	25	21	september	september	PROPN
ct-9952	25	22	2019	2019	NUM
ct-9952	26	1	414clinical	414clinical	PROPN
ct-9952	26	2	theriogenology	theriogenology	NOUN
ct-9952	26	3	•	•	NOUN
ct-9952	26	4	volume	volume	NOUN
ct-9952	26	5	11	11	NUM
ct-9952	26	6	,	,	PUNCT
ct-9952	26	7	number	number	NOUN
ct-9952	26	8	3	3	NUM
ct-9952	26	9	•	•	NUM
ct-9952	26	10	september	september	PROPN
ct-9952	26	11	2019	2019	NUM
ct-9952	26	12	omniblank	omniblank	NOUN
ct-9952	26	13	:	:	PUNCT